Lanean...
Liposomal adjuvant development for leishmaniasis vaccines
Leishmaniasis is a parasitic disease that ranges in severity from skin lesions to fatality. Since long-lasting protection is induced upon recovery from cutaneous leishmaniasis, development of an effective vaccine is promising. However, there is no vaccine for use in humans yet. It seems limited effi...
Gorde:
| Argitaratua izan da: | Ther Adv Vaccines |
|---|---|
| Egile Nagusiak: | , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
SAGE Publications
2017
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5697592/ https://ncbi.nlm.nih.gov/pubmed/29201374 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2051013617741578 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|